Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
McKinsey
Moodys
Dow
AstraZeneca

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Barr Labs Inc Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?

BARR LABS INC has seventeen approved drugs.

There are two tentative approvals on BARR LABS INC drugs.

Summary for Barr Labs Inc
US Patents:0
Tradenames:16
Ingredients:15
NDAs:17

Drugs and US Patents for Barr Labs Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Inc MINOCYCLINE HYDROCHLORIDE minocycline hydrochloride TABLET, EXTENDED RELEASE;ORAL 065485-007 Apr 26, 2017 AB RX No No   Start Trial   Start Trial
Barr Labs Inc DEXTROAMP SACCHARATE,AMP ASPARTATE,DEXTROAMP SULFATE AND AMP SULFATE amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 076536-005 Feb 12, 2013 AB RX No No   Start Trial   Start Trial
Barr Labs Inc OLANZAPINE olanzapine TABLET, ORALLY DISINTEGRATING;ORAL 077243-003 Jan 30, 2012 AB RX No No   Start Trial   Start Trial
Barr Labs Inc ESTRADIOL estradiol TABLET;ORAL 040197-002 Oct 22, 1997 AB RX No No   Start Trial   Start Trial
Barr Labs Inc ESTRADIOL estradiol TABLET;ORAL 040197-003 Oct 22, 1997 AB RX No Yes   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Merck
Mallinckrodt
Dow
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.